Suchergebnisse - "Harada, Yohei"

PubPharm (6)

1

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer

enthalten in: BMC cancer | 2023

von Harada, Y. | Sato, A. | Nakamura, H. | +8

2

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer

enthalten in: BMC cancer | 2023

von Harada, Y. | Sato, A. | Nakamura, H. | +8

3

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer

enthalten in: BMC cancer | 2023

von Harada, Y. | Sato, A. | Nakamura, H. | +8

4

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test

enthalten in: Cellular oncology (Dordrecht) | 2022

von Harada, Y. | Sato, A. | Araki, M. | +9

5

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test

enthalten in: Cellular oncology | 2022

von Harada, Y. | Sato, A. | Araki, M. | +9

6

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test

enthalten in: Cellular oncology | 2022

von Harada, Y. | Sato, A. | Araki, M. | +9

1
[1]